Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2023 and 2024.
-
Tight liquidity NBB
Cash and receivables cover 27 % of short-term debt in 2024; threshold 65 %.
Financials
Financial year 2024
NEUROPRAKT from Hasselt, company number BE0458571458, closed financial year 2024 with a result of € -14,830 after tax. For that financial year NEUROPRAKT recorded a gross margin of € 59,869 and equity of € 33,296. Compared with financial year 2023, the result moved from € -488 to € -14,830. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 30, 2025.
€ 33,296
▼ 31% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -14,830
▼ 2941 % more loss than in 2023
Profit after tax over the fiscal year.
€ 6,853
▲ 23% vs 2023
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 27,098.
People and assets in 2024
€ 68,505
▲ 35% vs 2023
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
€ 6,996
▲ 11% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 10,556
▲ 31% vs 2023
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 52,980 | € 50,324 | € 54,924 | € 59,869 | ▲ 9% |
| Profit after taxes | € 2,194 | € -5,529 | € -488 | € -14,830 | ▼ € 14,342 |
| Equity | € 54,142 | € 48,613 | € 48,125 | € 33,296 | ▼ 31% |
| Total debts | € 11,809 | € 31,860 | € 19,551 | € 25,212 | ▲ 29% |
| Cash | € 33,448 | € 68,075 | € 5,581 | € 6,853 | ▲ 23% |
| Land & buildings | € 17,340 | € 9,016 | € 9,016 | € 9,016 | |
| Retained profit | € 47,945 | € 42,416 | € 41,928 | € 27,098 | ▼ 35% |
| Balance sheet total | € 65,952 | € 80,473 | € 67,677 | € 58,507 | ▼ 14% |
Key figures of NEUROPRAKT, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 30 April 2026.
What happened to NEUROPRAKT?
What happened at NEUROPRAKT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: loss of € 14,830. Source: NBB ↗
- New establishment in Hasselt. KBO
- Start of the company according to the CBE. KBO
In short
From € 2,194 profit in 2021 to € 14,830 loss in 2024.
Best year ever: 2021, with € 2,194 profit.
A new publication or filing at NEUROPRAKT? We notify you, reason included.
Follow NEUROPRAKTDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Neuromeer, DR. HERMANS SYLVIA, DR. Dhollander Isabel, dr. K. Reekmans, neurologie, DR. DELMOTTE KOEN, NEUROLOGIE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
NEUROPRAKTBehind NEUROPRAKT are Sylvia Hermans, Nina De Klippel, Isabel Dhollander and Peter Soors. The shares are held by Neuromeer (20%), DR. HERMANS SYLVIA (14.3%), DR. Dhollander Isabel (14.3%), dr. K. Reekmans, neurologie (14.3%) and DR. DELMOTTE KOEN, NEUROLOGIE (14%).
Directors
According to the 2024 annual accounts
Shareholders
20%
14.3%
14.3%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Sint-Martinusplein 4B
3500 Hasselt
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
GOOGLE-CLOUD-PLATFORM - Google LLC, US
Website info
Features
Security
Details
- Company number
- 0458.571.458
- VAT number
- BE 0458.571.458
- Registered office
- Sint-Martinusplein 4B, 3500 Hasselt
- Names & denominations
- NEUROPRAKT
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 29 July 1996
- Peppol
- Active · Active since 17 Mar 2026
- Contact
- neurologiehasselt.be +3211241214
- Activities · NACE
Activiteiten van medisch specialisten